# Nicardipine vs Esmolol Craniotomy Emergence

> **NCT01951950** · PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 40 (actual)

## Conditions studied

- Brain Tumors

## Interventions

- **DRUG:** Nicardipine
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT01951950
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951950, "Nicardipine vs Esmolol Craniotomy Emergence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01951950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*